Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.

about

Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis.Recent trends (2016-2017) in the treatment of inflammatory bowel disease.

P2860

Q55438978-12317F13-D946-4D97-A195-256575013A69 Q55690193-79791A9E-D994-4620-9F85-15BE2C6CF12D

P2860

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.

Item

http://www.wikidata.org/entity/Q40072921

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.

@en

type

Item

label

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.

@en

prefLabel

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.

@en

P1476

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.

@en

P2093

Amy L Lightner

http://www.w3.org/2001/XMLSchema#string

John H Pemberton

http://www.w3.org/2001/XMLSchema#string

Kellie L Mathis

http://www.w3.org/2001/XMLSchema#string

Laura E Raffals

http://www.w3.org/2001/XMLSchema#string

Nicholas P McKenna

http://www.w3.org/2001/XMLSchema#string

Sara Moncrief

http://www.w3.org/2001/XMLSchema#string

P2860

Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies.

The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis.

Complications of ileoanal pouches.

Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease.

Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.

Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.

A Multicentre Evaluation of Risk Factors for Anastomotic Leakage After Restorative Proctocolectomy with Ileal Pouch-Anal Anastomosis for Inflammatory Bowel Disease.

Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis.

Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease.

P31

scholarly article

P356

10.1097/MIB.0000000000001248

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28858072

http://www.w3.org/2001/XMLSchema#string

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.

about

P2860

P2860

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698